Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #120174 on Biotech Values
ghmm
05/17/11 6:16 PM
#120183 RE: DewDiligence #120174
08/09/11 9:16 PM
#124909 RE: DewDiligence #120174
raised US $40 million through the private placement of approximately 13,724,000 shares of its common stock to new pharmaceutical and financial investors. The proceeds will be used to fund the ongoing development of ENB-0040, Enobia's enzyme replacement therapy (ERT) for hypophosphatasia, a rare and potentially life threatening genetic bone disorder for which there is no currently approved therapy.